Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing Efficacy of Budesonide Via MAD or INSI in Post-operative Treatment of CRS
NCT04267042Phase 1Unknown
- Sponsor
- St. Paul's Hospital
- Start
- Feb 2020
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised trial of budesonide in chronic rhinosinusitis (CRS) (2 arms), sponsored by St. Paul's Hospital. Primary endpoints: Sino-nasal Outcome Test-22 at 6 months and Modified Lund-Kennedy endoscopic score at 6 months. Status: unknown.
02
Drugs
budesonide
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT04267042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04267042.